These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 32088247
1. Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus. Nagib MM, Yu Y, Jiang J. Pharmacol Ther; 2020 May; 209():107504. PubMed ID: 32088247 [Abstract] [Full Text] [Related]
4. Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus. Rojas A, Ganesh T, Lelutiu N, Gueorguieva P, Dingledine R. Neuropharmacology; 2015 Jun; 93():15-27. PubMed ID: 25656476 [Abstract] [Full Text] [Related]
6. Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats. Rojas A, Ganesh T, Manji Z, O'neill T, Dingledine R. Neuropharmacology; 2016 Nov; 110(Pt A):419-430. PubMed ID: 27477533 [Abstract] [Full Text] [Related]
7. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus. Jiang J, Yang MS, Quan Y, Gueorguieva P, Ganesh T, Dingledine R. Neurobiol Dis; 2015 Apr; 76():126-136. PubMed ID: 25600211 [Abstract] [Full Text] [Related]
10. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Jiang J, Ganesh T, Du Y, Quan Y, Serrano G, Qui M, Speigel I, Rojas A, Lelutiu N, Dingledine R. Proc Natl Acad Sci U S A; 2012 Feb 21; 109(8):3149-54. PubMed ID: 22323596 [Abstract] [Full Text] [Related]
12. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells. Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT. Clin Exp Allergy; 2013 Jul 21; 43(7):741-51. PubMed ID: 23786281 [Abstract] [Full Text] [Related]
13. Preclinical development of an EP2 antagonist for post-seizure cognitive deficits. Varvel NH, Amaradhi R, Espinosa-Garcia C, Duddy S, Franklin R, Banik A, Alemán-Ruiz C, Blackmer-Raynolds L, Wang W, Honore T, Ganesh T, Dingledine R. Neuropharmacology; 2023 Feb 15; 224():109356. PubMed ID: 36460083 [Abstract] [Full Text] [Related]
17. Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics. Yu Y, Li L, Nguyen DT, Mustafa SM, Moore BM, Jiang J. Mol Neurobiol; 2020 Jun 15; 57(6):2830-2845. PubMed ID: 32378121 [Abstract] [Full Text] [Related]
18. A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition. Rojas A, Ganesh T, Wang W, Wang J, Dingledine R. Neurobiol Dis; 2020 Jan 15; 133():104399. PubMed ID: 30818067 [Abstract] [Full Text] [Related]
19. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle. Michael JV, Gavrila A, Nayak AP, Pera T, Liberato JR, Polischak SR, Shah SD, Deshpande DA, Penn RB. FASEB J; 2019 Apr 15; 33(4):4780-4789. PubMed ID: 30601680 [Abstract] [Full Text] [Related]